Episode Details
Back to EpisodesThe promise, and risk, of a new Alzheimer’s drug
Published 2 years, 8 months ago
Description
The FDA granted full approval to a new Alzheimer’s drug meant to slow the disease. There are some risks to the treatment. NBC News has the story.
The Washington Post looks at why many ultraprocessed foods are unhealthy.
The extreme heat is making squirrels and other creatures “sploot.” NPR explains how it’s a sign that animals are struggling with climate change.